Growth Metrics

Merck (MRK) FCF Margin (2016 - 2025)

Merck (MRK) has disclosed FCF Margin for 17 consecutive years, with 11.12% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 496.0% to 11.12% in Q4 2025 year-over-year; TTM through Dec 2025 was 19.01%, a 919.0% decrease, with the full-year FY2025 number at 19.01%, down 919.0% from a year prior.
  • FCF Margin was 11.12% for Q4 2025 at Merck, down from 39.56% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 51.08% in Q3 2024 to a low of 5.08% in Q4 2023.
  • A 5-year average of 20.47% and a median of 19.98% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: soared 2227bps in 2022, then tumbled -2880bps in 2023.
  • Merck's FCF Margin stood at 28.75% in 2021, then dropped by -17bps to 23.72% in 2022, then crashed by -121bps to 5.08% in 2023, then surged by 417bps to 16.08% in 2024, then plummeted by -31bps to 11.12% in 2025.
  • Per Business Quant, the three most recent readings for MRK's FCF Margin are 11.12% (Q4 2025), 39.56% (Q3 2025), and 16.0% (Q2 2025).